Published in FEBS Lett on June 23, 1997
Convergence of multiple signaling cascades at glycogen synthase kinase 3: Edg receptor-mediated phosphorylation and inactivation by lysophosphatidic acid through a protein kinase C-dependent intracellular pathway. Mol Cell Biol (2002) 1.91
Cytosolic phospholipase A2 and lysophospholipids in tumor angiogenesis. J Natl Cancer Inst (2010) 1.78
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Autotaxin is released from adipocytes, catalyzes lysophosphatidic acid synthesis, and activates preadipocyte proliferation. Up-regulated expression with adipocyte differentiation and obesity. J Biol Chem (2003) 1.39
Transcriptional regulation of lysophosphatidic acid-induced interleukin-8 expression and secretion by p38 MAPK and JNK in human bronchial epithelial cells. Biochem J (2006) 1.34
Lysophosphatidic acid receptors 1 and 2 play roles in regulation of vascular injury responses but not blood pressure. Circ Res (2008) 1.20
Lysophosphatidic acid prevents apoptosis in fibroblasts via G(i)-protein-mediated activation of mitogen-activated protein kinase. Biochem J (2000) 1.15
Human platelets respond differentially to lysophosphatidic acids having a highly unsaturated fatty acyl group and alkyl ether-linked lysophosphatidic acids. Biochem J (2002) 1.10
Lysophospholipid receptor activation of RhoA and lipid signaling pathways. Biochim Biophys Acta (2012) 1.07
Alpha2-adrenergic receptor-mediated release of lysophosphatidic acid by adipocytes. A paracrine signal for preadipocyte growth. J Clin Invest (1998) 1.07
Lysophosphatidic acid in atherosclerotic diseases. Br J Pharmacol (2012) 1.01
Isolation of lysophosphatidic acid phosphatase from developing peanut cotyledons. Plant Physiol (2002) 1.00
Secretion of a lysophospholipase D activity by adipocytes: involvement in lysophosphatidic acid synthesis. J Lipid Res (2002) 0.97
Age-dependent loss of sperm production in mice via impaired lysophosphatidic acid signaling. Biol Reprod (2008) 0.94
Lysophosphatidic acid (LPA) signaling in vertebrate reproduction. Trends Endocrinol Metab (2010) 0.94
The phospholipase A1 activity of lysophospholipase A-I links platelet activation to LPA production during blood coagulation. J Lipid Res (2011) 0.93
Absence of the lysophosphatidic acid receptor LPA1 results in abnormal bone development and decreased bone mass. Bone (2011) 0.89
Production of lysophosphatidic acid in blister fluid: involvement of a lysophospholipase D activity. J Invest Dermatol (2005) 0.86
Ovarian cancer-derived lysophosphatidic acid stimulates secretion of VEGF and stromal cell-derived factor-1 alpha from human mesenchymal stem cells. Exp Mol Med (2010) 0.86
Phospholipases of mineralization competent cells and matrix vesicles: roles in physiological and pathological mineralizations. Int J Mol Sci (2013) 0.84
Lysophosphatidic acid causes endothelial dysfunction in porcine coronary arteries and human coronary artery endothelial cells. Atherosclerosis (2012) 0.83
Purification and characterization of a lysophosphatidic acid-specific phosphatase. Biochem J (1998) 0.82
Lysophosphatidic Acid Upregulates Laminin-332 Expression during A431 Cell Colony Dispersal. J Oncol (2010) 0.81
Proteomic identification of betaig-h3 as a lysophosphatidic acid-induced secreted protein of human mesenchymal stem cells: paracrine activation of A549 lung adenocarcinoma cells by betaig-h3. Mol Cell Proteomics (2011) 0.80
Anatomical location of LPA1 activation and LPA phospholipid precursors in rodent and human brain. J Neurochem (2015) 0.76
Crystal structures and biochemical studies of human lysophosphatidic acid phosphatase type 6. Protein Cell (2013) 0.75
Expression of lysophosphatidic acid receptors in the human lower esophageal sphincter. Exp Ther Med (2013) 0.75
A role for phosphoinositide 3-kinase in bacterial invasion. Science (1996) 2.46
Secretory phospholipase A2 generates the novel lipid mediator lysophosphatidic acid in membrane microvesicles shed from activated cells. Cell (1995) 1.99
Prognostic value of admission plasma glucose and HbA in acute myocardial infarction. Diabet Med (2004) 1.93
Relationship between flavonoid structure and inhibition of phosphatidylinositol 3-kinase: a comparison with tyrosine kinase and protein kinase C inhibition. Biochem Pharmacol (1997) 1.64
Wakefulness and loss of awareness: brain and brainstem interaction in the vegetative state. Neurology (2010) 1.61
Integrin-dependent translocation of phosphoinositide 3-kinase to the cytoskeleton of thrombin-activated platelets involves specific interactions of p85 alpha with actin filaments and focal adhesion kinase. J Cell Biol (1995) 1.57
A critical role for phosphoinositide 3-kinase upstream of Gab1 and SHP2 in the activation of ras and mitogen-activated protein kinases by epidermal growth factor. J Biol Chem (2000) 1.56
Phosphatidic and lysophosphatidic acid production in phospholipase C-and thrombin-treated platelets. Possible involvement of a platelet lipase. Biochimie (1978) 1.56
A genetic defect in phosphatidylcholine biosynthesis triggers apoptosis in Chinese hamster ovary cells. J Biol Chem (1996) 1.52
The phosphoinositol-3-kinase-protein kinase B/Akt pathway is critical for Pseudomonas aeruginosa strain PAK internalization. Mol Biol Cell (2005) 1.49
A simple and highly sensitive radioenzymatic assay for lysophosphatidic acid quantification. J Lipid Res (2000) 1.42
Intrahospital transport of critically ill patients (excluding newborns). Ann Fr Anesth Reanim (2011) 1.42
[Interscalene brachial plexus block for glenohumeral luxation in prehospital medicine]. Ann Fr Anesth Reanim (2008) 1.39
Endothelial function and mechanical arterial properties in children born small for gestational age: comparison with obese children. Horm Res Paediatr (2011) 1.38
Interaction of pp60c-src, phospholipase C, inositol-lipid, and diacyglycerol kinases with the cytoskeletons of thrombin-stimulated platelets. J Biol Chem (1991) 1.37
Lysophosphatidic acid-induced Ca2+ mobilization in human A431 cells: structure-activity analysis. Biochem J (1995) 1.26
Assessment of renal function in clinical practice at the bedside of burn patients. Br J Clin Pharmacol (2006) 1.21
Opioid-induced hyperalgesia in a mice model of orthopaedic pain: preventive effect of ketamine. Br J Anaesth (2009) 1.20
Potential involvement of adipocyte insulin resistance in obesity-associated up-regulation of adipocyte lysophospholipase D/autotaxin expression. Diabetologia (2005) 1.15
Biosynthetic labelling of platelet activating factor from radioactive acetate by stimulated platelets. Nature (1981) 1.15
Lipid products of phosphoinositide 3-kinase interact with Rac1 GTPase and stimulate GDP dissociation. J Biol Chem (1998) 1.15
Resistance to aspirin in vitro is associated with increased platelet sensitivity to adenosine diphosphate. Thromb Res (2002) 1.12
Flavonoids and the inhibition of PKC and PI 3-kinase. Gen Pharmacol (1999) 1.12
Studies on ether phospholipids. II. Comparative composition of various tissues from human, rat and guinea pig. Biochim Biophys Acta (1984) 1.11
Insulin, C-peptide and proinsulin for the biochemical diagnosis of hypoglycaemia related to endogenous hyperinsulinism. Eur J Endocrinol (2007) 1.11
Phosphatidylinositol 3,4,5-trisphosphate-dependent stimulation of phospholipase C-gamma2 is an early key event in FcgammaRIIA-mediated activation of human platelets. J Biol Chem (1998) 1.10
Lysophosphatidic acid synthesis and release. Prostaglandins Other Lipid Mediat (2001) 1.09
Hepatic lipase induces the formation of pre-beta 1 high density lipoprotein (HDL) from triacylglycerol-rich HDL2. A study comparing liver perfusion to in vitro incubation with lipases. J Biol Chem (1994) 1.09
Platelet membrane phospholipid asymmetry: from the characterization of a scramblase activity to the identification of an essential protein mutated in Scott syndrome. J Thromb Haemost (2011) 1.08
Effects of lysophosphatidic acid on proliferation and cytosolic Ca++ of human adult vascular smooth muscle cells in culture. Thromb Res (1999) 1.07
Involvement of platelet glycoprotein IIb-IIIa (alpha IIb-beta 3 integrin) in thrombin-induced synthesis of phosphatidylinositol 3',4'-bisphosphate. J Biol Chem (1991) 1.06
Relationship between phosphoinositide kinase activities and protein tyrosine phosphorylation in plasma membranes from A431 cells. Biochem J (1990) 1.06
Human platelet aggregation induced by 1-alkyl-lysophosphatidic acid and its analogs: a new group of phospholipid mediators? Biochem Biophys Res Commun (1982) 1.05
How do Shp2 mutations that oppositely influence its biochemical activity result in syndromes with overlapping symptoms? Cell Mol Life Sci (2007) 1.05
Production of phosphatidylinositol 3,4,5-trisphosphate and phosphatidic acid in platelet rafts: evidence for a critical role of cholesterol-enriched domains in human platelet activation. Biochemistry (2001) 1.05
An epidermal growth factor receptor/Gab1 signaling pathway is required for activation of phosphoinositide 3-kinase by lysophosphatidic acid. J Biol Chem (1999) 1.05
Characterization and properties of a phosphatidylinositol phosphodiesterase (phospholipase C) from platelet cytosol. FEBS Lett (1979) 1.04
Phosphatidylinositol 3-kinase inhibitors block aortic smooth muscle cell proliferation in mid-late G1 phase: effect on cyclin-dependent kinase 2 and the inhibitory protein p27KIP1. Biochem Biophys Res Commun (1998) 1.03
The novel inositol lipid phosphatidylinositol 3,4-bisphosphate is produced by human blood platelets upon thrombin stimulation. Biochem J (1990) 1.00
Tyrosine phosphorylation and relocation of SHIP are integrin-mediated in thrombin-stimulated human blood platelets. J Biol Chem (1997) 1.00
Progressive osseous heteroplasia: a model for the imprinting effects of GNAS inactivating mutations in humans. J Clin Endocrinol Metab (2010) 1.00
Localization of STRO-1, BMP-2/-3/-7, BMP receptors and phosphorylated Smad-1 during the formation of mouse periodontium. Tissue Cell (2007) 0.99
An interaction between apo C-III variants and protease inhibitors contributes to high triglyceride/low HDL levels in treated HIV patients. AIDS (2001) 0.99
Biochemical characterization of plasma membranes and intracellular membranes isolated from human platelets using Percoll gradients. Biochim Biophys Acta (1986) 0.99
The association of metabolic disorders with the metabolic syndrome is different in men and women. Ann Nutr Metab (2003) 0.98
Cytidylyltransferase translocation onto endoplasmic reticulum and increased de novo synthesis without phosphatidylcholine accumulation in Krebs-II ascite cells. Biochim Biophys Acta (1991) 0.97
Isolation and characterization of plasma membranes from krebs II ascite cells using Percoll gradient. Biochim Biophys Acta (1982) 0.97
The integrin alpha IIb/beta 3 in human platelet signal transduction. Biochem Pharmacol (2000) 0.97
Platelet activating factor (PAF-acether) promotes an early degradation of phosphatidylinositol-4,5-biphosphate in rabbit platelets. FEBS Lett (1983) 0.97
Serum triglycerides are a predictive factor for the development and the progression of renal and retinal complications in patients with type 1 diabetes. Diabetes Metab (2004) 0.97
Differential activation by fMet-Leu-Phe and phorbol ester of a plasma membrane phosphatidylcholine-specific phospholipase D in human neutrophil. FEBS Lett (1989) 0.96
Anti-thrombin therapy during warm ischemia and cold preservation prevents chronic kidney graft fibrosis in a DCD model. Am J Transplant (2009) 0.96
Phosphatidylcholine cycle and regulation of phosphatidylcholine biosynthesis by enzyme translocation. Biochim Biophys Acta (1994) 0.96
Studies on the substrate specificity of a carboxyl ester hydrolase from human pancreatic juice. I. Action on carboxyl esters, glycerides and phospholipids. Biochim Biophys Acta (1980) 0.95
Measurement of arachidonic acid liberation in thrombin-stimulated human platelets. Use of agents that inhibit both the cyclooxygenase and lipoxygenase enzymes. Biochim Biophys Acta (1985) 0.95
Apoprotein c-III and E-containing lipoparticles are markedly increased in HIV-infected patients treated with protease inhibitors: association with the development of lipodystrophy. J Clin Endocrinol Metab (2001) 0.93
Structure-activity analysis of the effects of lysophosphatidic acid on platelet aggregation. Biochemistry (1999) 0.92
Hepatic lipase promotes the uptake of HDL esterified cholesterol by the perfused rat liver: a study using reconstituted HDL particles of defined phospholipid composition. J Lipid Res (1994) 0.92
Identification and quantification of diacylglycerols in HDL and accessibility to lipase. J Lipid Res (1996) 0.92
Plasmalogen degradation by oxidative stress: production and disappearance of specific fatty aldehydes and fatty alpha-hydroxyaldehydes. Free Radic Biol Med (2001) 0.91
Annexin 5 as a potential regulator of annexin 1 phosphorylation by protein kinase C. In vitro inhibition compared with quantitative data on annexin distribution in human endothelial cells. Biochem J (1993) 0.91
Normal pregnancy in a woman with nesidioblastosis treated with somatostatin analog octreotide. J Endocrinol Invest (2004) 0.91
Inositol lipids, phosphatidate and diacylglycerol share stearoylarachidonoylglycerol as a common backbone in thrombin-stimulated human platelets. Biochem J (1984) 0.91
Human neutrophil phospholipase D activation by N-formylmethionyl-leucylphenylalanine reveals a two-step process for the control of phosphatidylcholine breakdown and oxidative burst. Biochem J (1992) 0.91
Tyrosine kinases and phosphoinositide metabolism in thrombin-stimulated human platelets. Biochem J (1993) 0.90
Modifications of bone and connective tissue after orthostatic bedrest. Osteoporos Int (2000) 0.90
Association of phosphatidylinositol kinase and phosphatidylinositol 4-phosphate kinase activities with the cytoskeleton in human platelets. FEBS Lett (1989) 0.89
Vascular smooth muscle cell spreading onto fibrinogen is regulated by calpains and phospholipase C. Biochem Biophys Res Commun (2001) 0.89
[The therapeutic utilization of magnesium: medical consequences]. Pharm Acta Helv (1992) 0.89
Lipid products of phosphoinositide 3-kinase and phosphatidylinositol 4',5'-bisphosphate are both required for ADP-dependent platelet spreading. J Biol Chem (1998) 0.89
Broad spectrum anti-platelet activity of ticlopidine and PCR 4099 involves the suppression of the effects of released ADP. Thromb Res (1987) 0.89